TAZIALYNN LYNAM: Open Payments
NPI 1699385872 · HILO, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 35 payments from 14 companies in 2025. Trend: 2023 $771 · 2024 $647 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $263 |
| ABBVIE INC. | 5 | $131 |
| Amgen Inc. | 5 | $110 |
| Inspire Medical Systems, Inc. | 1 | $83 |
| Indivior Inc. | 3 | $83 |
| Novo Nordisk Inc | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Braeburn Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
Products named: Epclusa, UBRELVY, INSPIRE, SUBLOCADE, OTEZLA, Ozempic, EVENITY, TRELEGY ELLIPTA.
Industry payments across HI — which companies pay providers there.
